Clene CLNN
NASDAQ CLNN
$3.65 -0.07 (-1.88%)
At close: Sep 10, 2026 · 4:00 PM EDT

Clene (CLNN) Total Non-Current Liabilities (2020 - 2026)

Clene (CLNN) posted Total Non-Current Liabilities of $31.7 million for Q2 2026, up 3.33% on a QoQ basis from $30.7 million in Q4 2025, and up 12.63% year-over-year from $28.1 million in Q2 2025.

Analysis

Clene (CLNN) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Clene has reported Total Non-Current Liabilities for 7 years, with the latest figure at $31.7 million in Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 12.63% year-over-year to $31.7 million in Q2 2026; TTM through Jun 2026 was $31.7 million, a 12.63% increase from a year earlier, with the FY2025 full-year figure at $30.7 million, down 3.14% from the prior year.
  • Total Non-Current Liabilities was $31.7 million for Q2 2026 at Clene, up from $30.7 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $41.3 million in Q4 2022, with the low at $28.1 million in Q2 2025.
  • Average Total Non-Current Liabilities over 5 years is $34.6 million, with a median of $35.1 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities increased 18.26% in 2023, then decreased 28.99% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $41.3 million in 2022, then fell by 9.18% to $37.5 million in 2023, then retreated by 15.52% to $31.7 million in 2024, then decreased by 3.14% to $30.7 million in 2025, then advanced by 3.33% to $31.7 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $31.7 million (Q2 2026), $30.7 million (Q4 2025), and $30.4 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 105.99 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn 106.45 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 16.16 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 48.34 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 100.86 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 32.04 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn - 1.53 Bn
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 1.40 Bn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 607.80 Mn
10 Clene 45.69 Mn 45.69 Mn 54,000.00 31.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.68 Mn
Dec 31, 2025 30.66 Mn
Sep 30, 2025 30.39 Mn
Jun 30, 2025 28.13 Mn
Mar 31, 2025 28.26 Mn
Dec 31, 2024 31.65 Mn
Sep 30, 2024 35.10 Mn
Jun 30, 2024 39.61 Mn
Mar 31, 2024 38.02 Mn
Dec 31, 2023 37.47 Mn
Sep 30, 2023 37.17 Mn
Jun 30, 2023 38.11 Mn
Mar 31, 2023 39.20 Mn
Dec 31, 2022 41.26 Mn
Sep 30, 2022 33.89 Mn
Jun 30, 2022 35.26 Mn
Mar 31, 2022 33.14 Mn
Dec 31, 2021 49.99 Mn
Sep 30, 2021 33.37 Mn
Jun 30, 2021 30.19 Mn